CN108813262A - A kind of compound probiotic solid beverage containing DHA algal oil - Google Patents
A kind of compound probiotic solid beverage containing DHA algal oil Download PDFInfo
- Publication number
- CN108813262A CN108813262A CN201810707929.6A CN201810707929A CN108813262A CN 108813262 A CN108813262 A CN 108813262A CN 201810707929 A CN201810707929 A CN 201810707929A CN 108813262 A CN108813262 A CN 108813262A
- Authority
- CN
- China
- Prior art keywords
- parts
- algal oil
- dha algal
- powder
- solid beverage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006041 probiotic Substances 0.000 title claims abstract description 39
- 235000018291 probiotics Nutrition 0.000 title claims abstract description 39
- 150000001875 compounds Chemical class 0.000 title claims abstract description 24
- 235000013361 beverage Nutrition 0.000 title claims abstract description 22
- 239000007787 solid Substances 0.000 title claims abstract description 22
- 230000000529 probiotic effect Effects 0.000 title claims abstract description 20
- 239000000843 powder Substances 0.000 claims abstract description 25
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 14
- 241000894006 Bacteria Species 0.000 claims abstract description 13
- 241000186016 Bifidobacterium bifidum Species 0.000 claims abstract description 7
- 229940002008 bifidobacterium bifidum Drugs 0.000 claims abstract description 7
- 239000006071 cream Substances 0.000 claims abstract description 7
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 7
- 239000004310 lactic acid Substances 0.000 claims abstract description 7
- 229920001353 Dextrin Polymers 0.000 claims abstract description 6
- 239000004375 Dextrin Substances 0.000 claims abstract description 6
- 235000019425 dextrin Nutrition 0.000 claims abstract description 6
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims abstract description 5
- 150000003271 galactooligosaccharides Chemical class 0.000 claims abstract description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 10
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 5
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 claims description 5
- 244000291414 Vaccinium oxycoccus Species 0.000 claims description 5
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 claims description 5
- 229930003268 Vitamin C Natural products 0.000 claims description 5
- 235000015197 apple juice Nutrition 0.000 claims description 5
- 235000004634 cranberry Nutrition 0.000 claims description 5
- 235000013399 edible fruits Nutrition 0.000 claims description 5
- 235000019154 vitamin C Nutrition 0.000 claims description 5
- 239000011718 vitamin C Substances 0.000 claims description 5
- 102000004407 Lactalbumin Human genes 0.000 claims description 4
- 108090000942 Lactalbumin Proteins 0.000 claims description 4
- 229920002774 Maltodextrin Polymers 0.000 claims description 4
- 239000005913 Maltodextrin Substances 0.000 claims description 4
- 239000004376 Sucralose Substances 0.000 claims description 4
- 229940035034 maltodextrin Drugs 0.000 claims description 4
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 4
- 235000019408 sucralose Nutrition 0.000 claims description 4
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 2
- 238000013329 compounding Methods 0.000 claims description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- 241000254697 Lactobacillus rhamnosus HN001 Species 0.000 claims 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims 1
- 229930006000 Sucrose Natural products 0.000 claims 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 1
- 239000000460 chlorine Substances 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 239000005720 sucrose Substances 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 abstract description 7
- 235000020824 obesity Nutrition 0.000 abstract description 7
- 210000004556 brain Anatomy 0.000 abstract description 5
- 238000011161 development Methods 0.000 abstract description 5
- 241000700159 Rattus Species 0.000 description 12
- 239000002131 composite material Substances 0.000 description 5
- 210000000936 intestine Anatomy 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 235000013305 food Nutrition 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 206010033307 Overweight Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 235000013406 prebiotics Nutrition 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 241000186012 Bifidobacterium breve Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000017701 Endocrine disease Diseases 0.000 description 1
- 206010018473 Glycosuria Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 235000013958 Lactobacillus casei Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000194020 Streptococcus thermophilus Species 0.000 description 1
- 208000002495 Uterine Neoplasms Diseases 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 238000000546 chi-square test Methods 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000005182 global health Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 229940017800 lactobacillus casei Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 206010046766 uterine cancer Diseases 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/515—Animalis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/531—Lactis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention discloses a kind of compound probiotic solid beverage containing DHA algal oil, its key points of the technical solution are that, the component including following parts by weight：Lactic acid bacteria compounds powder 45-55 parts, 3-7 parts of Bifidobacterium Bifidum Bi-07 of cream, 8-12 parts of B. animais Bb-12,45-55 parts of DHA algal oil powder, 140-160 parts of galactooligosaccharide, 280-320 parts of resistant dextrin；The present invention is intended to provide a kind of compound probiotic solid beverage containing DHA algal oil, can effectively pre- preventing obesity and fat bring complication, and facilitate brain intelligence development.
Description
Technical field
The present invention relates to a kind of solid beverages, more specifically, it relates to a kind of compound probiotic solid containing DHA algal oil
Beverage.
Background technique
Various sales informations and a large amount of cheap, high heat junk food modern societies are flooded with as the mankind enter,
Obesity has become global health problem, breast cancer, the uterine cancer, prostate, colon cancer caused due to obesity；Glycosuria
Disease, three high, endocrine disorders；Acne, more can also seriously affect people's the problems such as youth, alopecia, insomnia too early at color spot
Daily life, it is very limited for fat improvement means in world wide at present.
The organ that intestinal flora passes into silence as human body participates in the normal physiology function such as the immune of body, metabolism, development
Energy.Enteric flora disturbance is crossed in fat occurrence and development and is played a very important role, and probiotics is as a kind of fixed
It plants in the active microorganism in host intestine, enteric flora disturbance can be prevented well；From the point of view of quick short-term effect,
Probiotics can inhibit harmful bacteria breeding in the intestine, prevention or improve diarrhea, improve functions of intestines and stomach etc.；From the point of view of long term, often
Its intake probiotics can help to absorb nutritional ingredient, Reduce allergy reaction, enhancing people's immunity, reduce serum cholesterol, root
Improve the microecological balance of host in sheet, and then effectively prevents fat and obesity and bring complication.
The prior art, notification number disclose a kind of fat and reduction blood lipid for improving for the patent of CN107684567A
Composite probiotics preparations are mixed in proportion by following probiotics：Bifidobacterium breve：Lactobacillus acidophilus：Lactobacillus casei：
The active bacteria number ratio of streptococcus thermophilus is 0 .5-1 .5：0 .5-1 .5：0 .5-1 .5：0 .5-1 .5；The technical solution
It is disadvantageous in that：1. this composite probiotics preparations only include probiotics, the condition that probiotics individually survives is higher, and people eats
It into after viable bacteria, is easy to be killed by gastric acid and bile, after eventually arriving at enteron aisle, also (to be fixed on intestines in face of the problem of " field planting "
Road and the fusion of original flora, if field planting is unsuccessful to be excreted with excrement), since there are these problems, so only mending
Probiotics is filled, it is often ineffective；2. this composite probiotics preparations are overweight or fat mainly for the gestational period as it is sayed
Pregnant woman, the physical trait and brain intelligence feature of trimester maternal can pass to offspring between generation-inter-, and simple probiotics
Baby can only be made to have strong body, not can effectively improve the brain intelligence development of baby.
Summary of the invention
In view of the deficiencies of the prior art, the present invention intends to provide a kind of compound probiotic containing DHA algal oil
Solid beverage, can effectively pre- preventing obesity and fat bring complication, and facilitate brain intelligence development.
To achieve the above object, the present invention provides following technical solutions：A kind of compound probiotic solid containing DHA algal oil
Beverage, the component including following parts by weight：Lactic acid bacteria compounds powder 45-55 parts, 3-7 parts of Bifidobacterium Bifidum Bi-07 of cream, animal pair
8-12 parts of qi bacillus Bb-12,45-55 parts of DHA algal oil powder, 140-160 parts of galactooligosaccharide, 280-320 parts of resistant dextrin.
Preferably, the compound probiotic solid beverage containing DHA algal oil further includes the component of following parts by weight：Whey
0-220 parts of protein 18,140-160 parts of maltodextrin, 45-55 parts of apple juice powder, 23-27 parts of Cranberry fruit powder, vitamin C 3-
7 parts, 0.5-1 parts of Sucralose.
Preferably, the compound probiotic solid beverage containing DHA algal oil, the component including following parts by weight：Lactic acid
Bacterium compounds 50.35 parts of powder, newborn 5 parts of Bifidobacterium Bifidum Bi-07,10 parts of B. animais Bb-12,50 parts of DHA algal oil powder, oligomeric
150 parts of galactolipin, 301 parts of resistant dextrin, 200 parts of lactalbumin, 150 parts of maltodextrin, 50 parts of apple juice powder, Cranberry fruit
25 parts of powder, 5 parts of vitamin C, 0.75 part of Sucralose.
Preferably, the lactic acid bacteria compounding powder includes the component of following parts by weight：28-32 parts of oligofructose, rhamnose
1-2 parts of lactobacillus HN001,1-2 parts of Bifidobacterium Bifidum HN019 of cream.
In conclusion the present invention has the advantages that compared with prior art：
First, being that internal probiotics supplies nutrients by three big prebiotics, it is directly proliferated beneficial bacteria of intestinal tract, is merely supplemented relatively
Probiotics, can more effectively pre- preventing obesity and fat bring complication；
Second, containing DHA algal oil powder in compound probiotic solid beverage, the brain intelligence of fetus can be promoted to develop, and it is prebiotic
Bacterium mutually cooperates with generation to act on, after the gestational period is overweight or fat pregnant woman takes, can be improved infant physical fitness and
Intelligence.
Specific embodiment
The following describes the present invention further through the description of specific embodiments, but it is limit of the invention that this, which is not,
System, those skilled in the art's basic ideas according to the present invention can make various modifications or improvements, but without departing from this
The basic thought of invention, is all within the scope of the present invention.
Embodiment 1
A kind of compound probiotic solid beverage containing DHA algal oil, the component including following parts by weight：Lactic acid bacteria compounds powder
0.107g, newborn Bifidobacterium Bifidum Bi-07 0.01g, B. animais Bb-12 0.02g, DHA algal oil powder 0.1g, galactooligosaccharide
0.3g, resistant dextrin 0.602g, lactalbumin 0.4g, maltodextrin 0.3g, apple juice powder 0.1g, Cranberry fruit powder 0.05g,
Vitamin C 0.01g, Sucralose 0.0015g.
The preparation method of the above-described compound probiotic solid beverage containing DHA algal oil comprising following steps：
1）It by each component outside above-mentioned removing probiotics, is put into container by weight ratio, then with stirring rod with 30r/min
Speed stir 5 minutes so that each raw material and auxiliary material are sufficiently mixed uniformly, it is spare to obtain mixed material；
2）Probiotics in above-mentioned component is added to step 1 by weight ratio）In obtained mixed material, then with 30r/
The speed of min stirs 5 minutes, until uniform colorless is poor, obtains the probiotic composition material；
3）By step 2）Obtained probiotic composition material carries out pouch packing, seals and drinks to get probiotics solid of the invention
Material.
Usage mode：One bag of probiotics solid beverage is taken, with appropriate warm water（37 DEG C or less）It reconstitutes edible.
Experimental example
50 gestational period female rats are chosen, are divided into treatment group and control group by the above female rat, every group each 25.To the mouse of two groups of female rats
The comparison of the basic documents such as age, symptom, weight, no significant difference, p>0.05, it is comparable.
Test method
To the isodose high lipid food of the equal feeding of the gestational period female rat for the treatment of group and control group, wherein fed to the female rat for the treatment of group
The fixed beverage of probiotics while high lipid food in daily one bag of embodiment 1 of feeding is eaten, the weight of female rat is observed after raising 8 weeks
Variation.
Curative effect determinate standard
The changes of weight of two groups of female rats is compared, wherein effective is weight loss after raising 8 weeks；It is effectively after raising 8 weeks
Weight is relatively unchanged；Invalid is weight gain after raising 8 weeks.Total effective rate is：[(effective number of cases+effective number of cases)/total example
Number] %.The changes of weight of two groups of female rats is compared.
Statistical method
This experimental data carries out statistical analysis using SPSS13.0 software, and wherein measurement data comparison is examined using t, counts
Information contrast uses Chi-square Test, is that difference is statistically significant with p < 0.05.
Test result
25 gestational period female rats for the treatment of group effective 16, proportion 64%, effective 6, proportion starves 24%, total effective rate
It is 88.0%；25 gestational period female rats of control group effective 0, proportion 0%, effective 3, proportion 12% is total effective
Rate is 12%.Comparing result between two groups of female rat therapeutic effects shows that the comparison treatment group between two groups of female rat therapeutic effects is excellent
In control group, containing statistically significant（p<0.05）.According to statistical result, a kind of answering containing DHA algal oil of the present invention can be obtained
Closing probiotics solid beverage being capable of the effective conclusion of pre- preventing obesity and fat bring complication.
Claims (4)
1. a kind of compound probiotic solid beverage containing DHA algal oil, which is characterized in that the component including following parts by weight：Cream
Sour bacterium compounds powder 45-55 parts, 3-7 parts of Bifidobacterium Bifidum Bi-07 of cream, 8-12 parts of B. animais Bb-12, DHA algal oil powder 45-
55 parts, 140-160 parts of galactooligosaccharide, 280-320 parts of resistant dextrin.
2. a kind of compound probiotic solid beverage containing DHA algal oil according to claim 1, which is characterized in that described to contain
The compound probiotic solid beverage of DHA algal oil further includes the component of following parts by weight：180-220 parts of lactalbumin, malt paste
140-160 parts smart, 45-55 parts of apple juice powder, 23-27 parts of Cranberry fruit powder, 3-7 parts of vitamin C, 0.5-1 parts of Sucralose.
3. a kind of compound probiotic solid beverage containing DHA algal oil according to claim 2, which is characterized in that described to contain
The compound probiotic solid beverage of DHA algal oil, the component including following parts by weight：Lactic acid bacteria compounds the double qis of 50.35 parts of powder, cream
5 parts of bacillus Bi-07,10 parts of B. animais Bb-12,50 parts of DHA algal oil powder, 150 parts of galactooligosaccharide, resistant dextrin
301 parts, 200 parts of lactalbumin, 150 parts of maltodextrin, 50 parts of apple juice powder, 25 parts of Cranberry fruit powder, 5 parts of vitamin C, three
0.75 part of chlorine sucrose.
4. a kind of compound probiotic solid beverage containing DHA algal oil according to claim 1-3, feature exist
In the lactic acid bacteria compounding powder includes the component of following parts by weight：28-32 parts of oligofructose, Lactobacillus rhamnosus HN001
1-2 parts, 1-2 parts of Bifidobacterium Bifidum HN019 of cream.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810707929.6A CN108813262A (en) | 2018-07-02 | 2018-07-02 | A kind of compound probiotic solid beverage containing DHA algal oil |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810707929.6A CN108813262A (en) | 2018-07-02 | 2018-07-02 | A kind of compound probiotic solid beverage containing DHA algal oil |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108813262A true CN108813262A (en) | 2018-11-16 |
Family
ID=64135074
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810707929.6A Pending CN108813262A (en) | 2018-07-02 | 2018-07-02 | A kind of compound probiotic solid beverage containing DHA algal oil |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108813262A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111109493A (en) * | 2020-01-20 | 2020-05-08 | 湖南膳养堂生物科技有限公司 | Intelligence-developing and growth-promoting micromolecule polypeptide solid beverage formula and preparation method thereof |
| CN114376136A (en) * | 2020-10-20 | 2022-04-22 | 沈阳美生药物研究所 | Formula of pawpaw vitamin C fruity beverage added with DHA algae oil powder |
| WO2023237684A1 (en) * | 2022-06-10 | 2023-12-14 | Dsm Ip Assets B.V. | Combinations comprising vitamin c and lactobacillus rhamnosus |
| WO2023237689A1 (en) * | 2022-06-10 | 2023-12-14 | Dsm Ip Assets B.V. | Combinations comprising vitamin c and lactobacillus rhamnosus |
| WO2023237686A1 (en) * | 2022-06-10 | 2023-12-14 | Dsm Ip Assets B.V. | Combinations comprising vitamin c and lactobacillus rhamnosus |
| WO2023237688A1 (en) * | 2022-06-10 | 2023-12-14 | Dsm Ip Assets B.V. | Combinations comprising vitamin c and lactobacillus rhamnosus |
Citations (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1223821A (en) * | 1998-01-20 | 1999-07-28 | 沈云冲 | Natural brain-invigorating beverage |
| CN1863463A (en) * | 2003-06-23 | 2006-11-15 | 雀巢技术公司 | Nutritional formula for optimal gut barrier function |
| CN101173228A (en) * | 2006-11-01 | 2008-05-07 | 信谊药厂 | Novel lactic acid bacillus mycopremna, pharmaceutical composition and uses thereof, and production method |
| WO2008071930A1 (en) * | 2006-12-11 | 2008-06-19 | Danisco A/S | Composition |
| WO2010123351A1 (en) * | 2009-04-20 | 2010-10-28 | Friesland Brands B.V. | Satiety inducing milk product |
| CN101897358A (en) * | 2009-05-27 | 2010-12-01 | 光明乳业股份有限公司 | Solid beverage and preparation method thereof |
| CN101897729A (en) * | 2009-05-31 | 2010-12-01 | 金士力佳友(天津)有限公司 | Probiotic composition and preparation thereof |
| CN102090558A (en) * | 2010-12-09 | 2011-06-15 | 上海交大昂立股份有限公司 | Composition containing probiotics, DHA (docosahexaenoic acid) and lactoferrin and applications thereof |
| CN102448478A (en) * | 2009-03-25 | 2012-05-09 | 科·汉森有限公司 | Use of probiotics to ameliorate diet-induced insulin resistance |
| CN102448477A (en) * | 2009-03-25 | 2012-05-09 | 科·汉森有限公司 | Use of a probiotic to regulate body weight |
| CN102511714A (en) * | 2011-12-21 | 2012-06-27 | 浙江康恩贝健康产品有限公司 | High-activity probiotic composition suitable for infants and preparation method thereof |
| CN102550673A (en) * | 2012-02-18 | 2012-07-11 | 安徽曦强乳业集团有限公司 | Fruit yoghurt with balanced nutrition and production method thereof |
| CN103621633A (en) * | 2013-12-05 | 2014-03-12 | 刘保惠 | Infant series yak milk formula milk powder and preparation method thereof |
| CN103687495A (en) * | 2011-05-20 | 2014-03-26 | 弗里斯兰品牌有限公司 | Composition comprising vitamin k2 |
| CN104222281A (en) * | 2013-10-28 | 2014-12-24 | 山东文远生物技术有限公司 | Functional compound prebiotics and dairy product of functional compound prebiotics |
| CN104430899A (en) * | 2015-01-13 | 2015-03-25 | 光明乳业股份有限公司 | Hypoallergenic infant formula milk powder and preparation method thereof |
| CN104430846A (en) * | 2014-12-09 | 2015-03-25 | 柳州三元天爱乳业有限公司 | Process for producing natural probiotic yogurt |
| CN104473974A (en) * | 2014-11-18 | 2015-04-01 | 汤臣倍健股份有限公司 | Composition for adjusting stomachic and intestinal microflora as well as application and food of composition |
| CN104522469A (en) * | 2015-01-08 | 2015-04-22 | 李泼 | Functional food set meal capable of losing weight scientifically and healthily |
| CN104643250A (en) * | 2015-02-14 | 2015-05-27 | 河南省摇太阳食品有限公司 | Solid beverage capable of bidirectionally regulating body weight and improving subhealth |
| WO2015078507A1 (en) * | 2013-11-29 | 2015-06-04 | Nestec S.A | Liquid milk fortifier composition with relatively high lipid content |
| CN104968780A (en) * | 2012-09-20 | 2015-10-07 | 普洛特拉有限公司 | Probiotic compositions and methods for the treatment of obesity and obesity-related conditions |
| CN104983746A (en) * | 2015-06-18 | 2015-10-21 | 合生元（广州）健康产品有限公司 | Complex probiotics and preparation method |
| CN105076417A (en) * | 2015-07-29 | 2015-11-25 | 多加多乳业(天津)有限公司 | Intestine protective formula milk powder and preparation method thereof |
| CN105166914A (en) * | 2015-10-27 | 2015-12-23 | 江西美庐乳业集团有限公司 | Nutrition bag capable of regulating intestinal micro-ecological environment, promoting baby disease resistance and improving diarrhea |
| CN105725005A (en) * | 2016-02-03 | 2016-07-06 | 山东禹王制药有限公司 | Protein type solid beverage with DHA fishy smell improved and preparing method thereof |
| CN105746728A (en) * | 2016-03-14 | 2016-07-13 | 上海晨冠乳业有限公司 | Infant formula milk powder simulating breast milk and preparation method of infant formula milk powder |
| CN105875832A (en) * | 2016-04-19 | 2016-08-24 | 吴世凯 | Yoghourt containing seaweed oil and making method of yoghourt |
| BR102015014709A2 (en) * | 2015-05-27 | 2016-11-29 | Aquileine Mainomy Benício De Carvalho | probiotic fermented dairy drink based on whey and cashew pulp |
| CN106255505A (en) * | 2014-04-25 | 2016-12-21 | Mjn 美国控股有限责任公司 | There is the formulation compositions of human milk oligosaccharides, prebiotics and probiotic bacteria |
| CN106343580A (en) * | 2016-08-26 | 2017-01-25 | 上海晨冠乳业有限公司 | Novel high-calcium nutrient protein powder and preparation method thereof |
| CN106465829A (en) * | 2015-08-14 | 2017-03-01 | 爱礼康生物医药（苏州）有限公司 | Night using type dietary fiber solid beverage and preparation method thereof |
| CN106659226A (en) * | 2014-08-18 | 2017-05-10 | 雀巢产品技术援助有限公司 | Prebiotics for reducing the risk of obesity later in life |
| CN106689363A (en) * | 2016-11-18 | 2017-05-24 | 威海喜盈门乳品有限公司 | Lactic acid bacteria beverage with weight reducing function and preparation method thereof |
| CN106794206A (en) * | 2014-08-08 | 2017-05-31 | 雀巢产品技术援助有限公司 | Inositol and one or more probiotics and their purposes |
| CN106794204A (en) * | 2014-08-08 | 2017-05-31 | 雀巢产品技术援助有限公司 | Inositol and probiotics and application thereof |
| CN107106584A (en) * | 2014-12-08 | 2017-08-29 | 格礼卡姆股份公司 | Synthetic composition for treating dysbolism |
| CN107156587A (en) * | 2017-06-05 | 2017-09-15 | 北京天宝瑞健康科技有限公司 | Active probiotic solid beverage and its treatment diabetes B in apply |
| CN107212415A (en) * | 2017-05-18 | 2017-09-29 | 江西长通实业有限公司 | A kind of 5-linked probiotics nutrient powder and preparation method thereof |
| CN107279649A (en) * | 2017-07-25 | 2017-10-24 | 杭州诺利康健康管理有限公司 | A kind of probiotics solid beverage formula and its manufacture method |
| CN107280014A (en) * | 2017-08-02 | 2017-10-24 | 安徽金源药业有限公司 | It is a kind of to promote the compound probiotic protein powder of Instestinal motility |
| EP3135753A4 (en) * | 2014-03-24 | 2017-11-01 | Otsuka Pharmaceutical Co., Ltd. | Novel lactobacillus paracasei strain |
| CN107410812A (en) * | 2017-06-20 | 2017-12-01 | 陈光永 | A kind of probiotics solid beverage and preparation method thereof |
| CN107712873A (en) * | 2010-12-01 | 2018-02-23 | N·V·努特里奇亚 | Overweight and fat prevention or treatment in diabetes B patient |
| CN107889999A (en) * | 2017-11-28 | 2018-04-10 | 天津活力达生物科技有限公司 | Fruits and vegetables composite enzyme solid beverage with adjustment function of intestinal canal and preparation method thereof |
| CN108013136A (en) * | 2017-11-29 | 2018-05-11 | 上海晨冠乳业有限公司 | A kind of Milk powder for middle-aged and old people of multidimensional high calcium and preparation method thereof |
| CN108125094A (en) * | 2017-06-14 | 2018-06-08 | 王学勇 | A kind of purposes of preparation and its blood lipid-reducing blood sugar-decreasing based on resistant starch composite dietary solid beverage |
-
2018
- 2018-07-02 CN CN201810707929.6A patent/CN108813262A/en active Pending
Patent Citations (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1223821A (en) * | 1998-01-20 | 1999-07-28 | 沈云冲 | Natural brain-invigorating beverage |
| CN1863463A (en) * | 2003-06-23 | 2006-11-15 | 雀巢技术公司 | Nutritional formula for optimal gut barrier function |
| CN101173228A (en) * | 2006-11-01 | 2008-05-07 | 信谊药厂 | Novel lactic acid bacillus mycopremna, pharmaceutical composition and uses thereof, and production method |
| WO2008071930A1 (en) * | 2006-12-11 | 2008-06-19 | Danisco A/S | Composition |
| US20100092429A1 (en) * | 2006-12-11 | 2010-04-15 | Danisco A/S | Composition |
| CN102448478A (en) * | 2009-03-25 | 2012-05-09 | 科·汉森有限公司 | Use of probiotics to ameliorate diet-induced insulin resistance |
| CN102448477A (en) * | 2009-03-25 | 2012-05-09 | 科·汉森有限公司 | Use of a probiotic to regulate body weight |
| WO2010123351A1 (en) * | 2009-04-20 | 2010-10-28 | Friesland Brands B.V. | Satiety inducing milk product |
| CN101897358A (en) * | 2009-05-27 | 2010-12-01 | 光明乳业股份有限公司 | Solid beverage and preparation method thereof |
| CN101897729A (en) * | 2009-05-31 | 2010-12-01 | 金士力佳友(天津)有限公司 | Probiotic composition and preparation thereof |
| CN107712873A (en) * | 2010-12-01 | 2018-02-23 | N·V·努特里奇亚 | Overweight and fat prevention or treatment in diabetes B patient |
| CN102090558A (en) * | 2010-12-09 | 2011-06-15 | 上海交大昂立股份有限公司 | Composition containing probiotics, DHA (docosahexaenoic acid) and lactoferrin and applications thereof |
| CN103687495A (en) * | 2011-05-20 | 2014-03-26 | 弗里斯兰品牌有限公司 | Composition comprising vitamin k2 |
| CN102511714A (en) * | 2011-12-21 | 2012-06-27 | 浙江康恩贝健康产品有限公司 | High-activity probiotic composition suitable for infants and preparation method thereof |
| CN102550673A (en) * | 2012-02-18 | 2012-07-11 | 安徽曦强乳业集团有限公司 | Fruit yoghurt with balanced nutrition and production method thereof |
| CN104968780A (en) * | 2012-09-20 | 2015-10-07 | 普洛特拉有限公司 | Probiotic compositions and methods for the treatment of obesity and obesity-related conditions |
| CN104222281A (en) * | 2013-10-28 | 2014-12-24 | 山东文远生物技术有限公司 | Functional compound prebiotics and dairy product of functional compound prebiotics |
| WO2015078507A1 (en) * | 2013-11-29 | 2015-06-04 | Nestec S.A | Liquid milk fortifier composition with relatively high lipid content |
| CN103621633A (en) * | 2013-12-05 | 2014-03-12 | 刘保惠 | Infant series yak milk formula milk powder and preparation method thereof |
| EP3135753A4 (en) * | 2014-03-24 | 2017-11-01 | Otsuka Pharmaceutical Co., Ltd. | Novel lactobacillus paracasei strain |
| CN106255505A (en) * | 2014-04-25 | 2016-12-21 | Mjn 美国控股有限责任公司 | There is the formulation compositions of human milk oligosaccharides, prebiotics and probiotic bacteria |
| CN106794204A (en) * | 2014-08-08 | 2017-05-31 | 雀巢产品技术援助有限公司 | Inositol and probiotics and application thereof |
| CN106794206A (en) * | 2014-08-08 | 2017-05-31 | 雀巢产品技术援助有限公司 | Inositol and one or more probiotics and their purposes |
| CN106659226A (en) * | 2014-08-18 | 2017-05-10 | 雀巢产品技术援助有限公司 | Prebiotics for reducing the risk of obesity later in life |
| CN104473974A (en) * | 2014-11-18 | 2015-04-01 | 汤臣倍健股份有限公司 | Composition for adjusting stomachic and intestinal microflora as well as application and food of composition |
| CN107106584A (en) * | 2014-12-08 | 2017-08-29 | 格礼卡姆股份公司 | Synthetic composition for treating dysbolism |
| CN104430846A (en) * | 2014-12-09 | 2015-03-25 | 柳州三元天爱乳业有限公司 | Process for producing natural probiotic yogurt |
| CN104522469A (en) * | 2015-01-08 | 2015-04-22 | 李泼 | Functional food set meal capable of losing weight scientifically and healthily |
| CN104430899A (en) * | 2015-01-13 | 2015-03-25 | 光明乳业股份有限公司 | Hypoallergenic infant formula milk powder and preparation method thereof |
| CN104643250A (en) * | 2015-02-14 | 2015-05-27 | 河南省摇太阳食品有限公司 | Solid beverage capable of bidirectionally regulating body weight and improving subhealth |
| BR102015014709A2 (en) * | 2015-05-27 | 2016-11-29 | Aquileine Mainomy Benício De Carvalho | probiotic fermented dairy drink based on whey and cashew pulp |
| CN104983746A (en) * | 2015-06-18 | 2015-10-21 | 合生元（广州）健康产品有限公司 | Complex probiotics and preparation method |
| CN105076417A (en) * | 2015-07-29 | 2015-11-25 | 多加多乳业(天津)有限公司 | Intestine protective formula milk powder and preparation method thereof |
| CN106465829A (en) * | 2015-08-14 | 2017-03-01 | 爱礼康生物医药（苏州）有限公司 | Night using type dietary fiber solid beverage and preparation method thereof |
| CN105166914A (en) * | 2015-10-27 | 2015-12-23 | 江西美庐乳业集团有限公司 | Nutrition bag capable of regulating intestinal micro-ecological environment, promoting baby disease resistance and improving diarrhea |
| CN105725005A (en) * | 2016-02-03 | 2016-07-06 | 山东禹王制药有限公司 | Protein type solid beverage with DHA fishy smell improved and preparing method thereof |
| CN105746728A (en) * | 2016-03-14 | 2016-07-13 | 上海晨冠乳业有限公司 | Infant formula milk powder simulating breast milk and preparation method of infant formula milk powder |
| CN105875832A (en) * | 2016-04-19 | 2016-08-24 | 吴世凯 | Yoghourt containing seaweed oil and making method of yoghourt |
| CN106343580A (en) * | 2016-08-26 | 2017-01-25 | 上海晨冠乳业有限公司 | Novel high-calcium nutrient protein powder and preparation method thereof |
| CN106689363A (en) * | 2016-11-18 | 2017-05-24 | 威海喜盈门乳品有限公司 | Lactic acid bacteria beverage with weight reducing function and preparation method thereof |
| CN107212415A (en) * | 2017-05-18 | 2017-09-29 | 江西长通实业有限公司 | A kind of 5-linked probiotics nutrient powder and preparation method thereof |
| CN107156587A (en) * | 2017-06-05 | 2017-09-15 | 北京天宝瑞健康科技有限公司 | Active probiotic solid beverage and its treatment diabetes B in apply |
| CN108125094A (en) * | 2017-06-14 | 2018-06-08 | 王学勇 | A kind of purposes of preparation and its blood lipid-reducing blood sugar-decreasing based on resistant starch composite dietary solid beverage |
| CN107410812A (en) * | 2017-06-20 | 2017-12-01 | 陈光永 | A kind of probiotics solid beverage and preparation method thereof |
| CN107279649A (en) * | 2017-07-25 | 2017-10-24 | 杭州诺利康健康管理有限公司 | A kind of probiotics solid beverage formula and its manufacture method |
| CN107280014A (en) * | 2017-08-02 | 2017-10-24 | 安徽金源药业有限公司 | It is a kind of to promote the compound probiotic protein powder of Instestinal motility |
| CN107889999A (en) * | 2017-11-28 | 2018-04-10 | 天津活力达生物科技有限公司 | Fruits and vegetables composite enzyme solid beverage with adjustment function of intestinal canal and preparation method thereof |
| CN108013136A (en) * | 2017-11-29 | 2018-05-11 | 上海晨冠乳业有限公司 | A kind of Milk powder for middle-aged and old people of multidimensional high calcium and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| JUNICHI MUKAI等: "Effects of resistant dextrin for weight loss in overweight adults：a systematic review with a meta-analysis of randomized controlled trials", 《JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES》 * |
| 孔欣欣: "DHA藻油生产技术及其在食品中的应用进展", 《食品与发酵科技》 * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111109493A (en) * | 2020-01-20 | 2020-05-08 | 湖南膳养堂生物科技有限公司 | Intelligence-developing and growth-promoting micromolecule polypeptide solid beverage formula and preparation method thereof |
| CN114376136A (en) * | 2020-10-20 | 2022-04-22 | 沈阳美生药物研究所 | Formula of pawpaw vitamin C fruity beverage added with DHA algae oil powder |
| WO2023237684A1 (en) * | 2022-06-10 | 2023-12-14 | Dsm Ip Assets B.V. | Combinations comprising vitamin c and lactobacillus rhamnosus |
| WO2023237689A1 (en) * | 2022-06-10 | 2023-12-14 | Dsm Ip Assets B.V. | Combinations comprising vitamin c and lactobacillus rhamnosus |
| WO2023237686A1 (en) * | 2022-06-10 | 2023-12-14 | Dsm Ip Assets B.V. | Combinations comprising vitamin c and lactobacillus rhamnosus |
| WO2023237688A1 (en) * | 2022-06-10 | 2023-12-14 | Dsm Ip Assets B.V. | Combinations comprising vitamin c and lactobacillus rhamnosus |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108813262A (en) | A kind of compound probiotic solid beverage containing DHA algal oil | |
| Buttriss | Nutritional properties of fermented milk products | |
| CN106794207A (en) | Using lactobacillus reuteri in life early recovery micropopulation ecological disturbance | |
| JP5864676B2 (en) | Composition for preventing or treating anemia | |
| CN107594279A (en) | A kind of probiotic powder solid beverage and preparation method thereof | |
| EP3079501B1 (en) | Synthetic nutritional compositions especially adapted for male and female infants and young children | |
| CN101564133B (en) | Soybean yogurt and preparation method thereof | |
| CN103582426A (en) | Oligosaccharide mixture and food product comprising this mixture, especially infant formula | |
| CN104206539A (en) | Probiotic-containing infant milk powder | |
| CN105792673A (en) | Use of nutritional compositions having a low protein amount | |
| CN101558786A (en) | Method for preparing active probiotic beverage and product thereof | |
| WO2021149663A1 (en) | Composition | |
| WO2015065194A1 (en) | Fermented formula with non digestible oligosaccharides | |
| CN109548956A (en) | A kind of pet nutrition liquid and preparation method thereof | |
| CN103250785B (en) | A kind of inulin low-fat yogurt pudding and preparation method thereof | |
| EP3177154B1 (en) | Myo-inositol and probiotics, and their use to prevent excess body weight in infants | |
| CN105076417A (en) | Intestine protective formula milk powder and preparation method thereof | |
| CA2953109A1 (en) | A combination of vitamin d and zinc and its use | |
| CN109588602A (en) | A kind of probiotics solid beverage | |
| CN102227223B (en) | Mineral absorption improver, and method for improving absorption of minerals | |
| CN111201026B (en) | Fermented milk and polysaccharides with cancer cachexia inhibiting effect | |
| CN110679663A (en) | Nutritional milk powder for children and preparation method thereof | |
| CN108523136A (en) | A kind of composition containing lactase | |
| CN104430877A (en) | Production process of passion fruit flavored probiotic yoghourt | |
| EP4056053A1 (en) | Pre-conditioning of l. reuteri |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181116 |